A detailed history of Gts Securities LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Gts Securities LLC holds 71,400 shares of BHC stock, worth $497,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,400
Previous 38,500 85.45%
Holding current value
$497,658
Previous $308,000 145.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$7.77 - $10.61 $583,387 - $796,620
75,082 New
75,082 $796,000
Q3 2023

Nov 15, 2023

SELL
$7.69 - $9.71 $95,386 - $120,442
-12,404 Reduced 10.66%
103,955 $854,000
Q2 2023

Aug 15, 2023

BUY
$5.72 - $8.8 $665,573 - $1.02 Million
116,359 New
116,359 $931 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.52B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.